PubMed:32616067 / 627-1079
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 62-65 | Body_part | denotes | arm | http://purl.org/sig/ont/fma/fma24890 |
| T2 | 297-300 | Body_part | denotes | arm | http://purl.org/sig/ont/fma/fma24890 |
| T3 | 355-358 | Body_part | denotes | arm | http://purl.org/sig/ont/fma/fma24890 |
| T4 | 425-428 | Body_part | denotes | arm | http://purl.org/sig/ont/fma/fma24890 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 62-65 | Body_part | denotes | arm | http://purl.obolibrary.org/obo/UBERON_0001460 |
| T2 | 297-300 | Body_part | denotes | arm | http://purl.obolibrary.org/obo/UBERON_0001460 |
| T3 | 355-358 | Body_part | denotes | arm | http://purl.obolibrary.org/obo/UBERON_0001460 |
| T4 | 425-428 | Body_part | denotes | arm | http://purl.obolibrary.org/obo/UBERON_0001460 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T6 | 28-36 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T7 | 187-195 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T8 | 274-282 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T9 | 315-323 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T10 | 392-400 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T11 | 401-410 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 62-65 | http://www.ebi.ac.uk/efo/EFO_0001410 | denotes | arm |
| T8 | 91-96 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T9 | 122-129 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T10 | 230-237 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T11 | 297-300 | http://www.ebi.ac.uk/efo/EFO_0001410 | denotes | arm |
| T12 | 355-358 | http://www.ebi.ac.uk/efo/EFO_0001410 | denotes | arm |
| T13 | 425-428 | http://www.ebi.ac.uk/efo/EFO_0001410 | denotes | arm |
| T14 | 441-451 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | OBJECTIVES |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 0-452 | Sentence | denotes | 2) To compare the number of COVID-19 cases between each trial arm on the basis of positive tests (as per current clinical testing methods and/or serology) 3) To compare the percentage of COVID-19 positive individuals with current testing methods versus serologically-proven COVID-19 in each trial arm 4) To compare COVID-19 disease severity in each trial arm 5) To compare recovery time from COVID-19 infection in each trial arm EXPLORATORY OBJECTIVES: |